Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and Females

Learn more about:
Related Clinical Trial
A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata Modified SALT Score for Alopecia Areata Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children Comparative Study Examining the Effectiveness in Use of a DERMOJET and a Normal Syringe Treatment for Patients With Hair Loss – Alopecia Areata TREg Activation in the Treatment of the PELADE (Alopecia Areata) The Effectiveness of Mindfulness Based Cognitive Group Therapy for Social Anxiety Symptoms in People Living With Alopecia Areata Response of Topical Capsaicin in Alopecia Areata Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata. Jaktinib Dihydrochloride Monohydrate in Severe Alopecia Areata Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needling Cryotherapy Versus Steroids In Alopecia Areata:Trichoscopic Evaluation Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade Stem Cell Educator Therapy in Alopecia Areata Comparative Study for Treatment of Alopecia Areata Using Carboxytherapy and Intralesional Steroids The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata Vytorin in the Treatment of Alopecia Areata Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata The Efficacy and Safety of Different Concentrations of Localized Injections of Steroids in the Treatment of Alopecia Areata Transepidermal Delivery of Triamcinolone Acetonide or Platelet Rich Plasma Using Either Fractional Carbon Dioxide Laser or Microneedling in Treatment of Alopecia Areata A Trial of Clobetasol Propionate Versus Hydrocortisone in Children With Alopecia Areata Efficacy and Safety of LH-8 in Paediatric Alopecia Areata Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata Intralesional Steroids in the Treatment of Alopecia Areata A Phase II Study in Patients With Alopecia Areata Topical Crisaborole in Patients With Alopecia Areata Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata Efficacy of Fractional CO2 Laser as a Mono- or Adjuvant Therapy for Alopecia Areata Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5% Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and Females Excimer Light for Alopecia Areata Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata Safety and Efficacy Study of SHAPE Gel in Alopecia Areata Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata Topical Garlic Concentrate for Alopecia Areata in Children Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata Aldara for the Treatment of Extensive Alopecia Areata A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata LEO 124249 Ointment in the Treatment of Alopecia Areata Childhood Alopecia Areata Study Using the 308-nm Excimer Laser Alefacept in Patients With Severe Scalp Alopecia Areata Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata

Brief Title

Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and Females


Brief Summary

      The purpose of this study is to determine whether the Hair Loss Prevention Lotion named
      MEXIS, M.P.A.F., M6S PATENT is effective in the treatment of Alopecia Areata.
    

Detailed Description

      This study verifies whether the tested product has any efficacy in the treatment of Alopecia
      Areata.

        -  The evaluated product (Hair Loss prevention Lotion) is called: MEXIS, MPAF, M6S PATENT.

        -  20 volunteers both men and women suffering from hair loss both in parties and over the
           entire scalp with age between 18 and 70 years will be selected for this test .

        -  Samples of the product have been applied following their usual use: as they are.

        -  On the selecting volunteers will be used:

      A polarized light video-camera to check the redness of the scalp and to have a picture of
      hair and scalp.

        -  Volunteers will also be asked about:

        -  Fluffiness

        -  Sheen

        -  Itching

        -  Presence of scales on scalp

        -  Oily hair

        -  Product's acceptability

        -  The readings will be taken at 0 time (basal value), after 15 days (t15), 30 days (t30),
           45 days (t45), 45 days (t45), 60 days (t60) and 90 days (t90) by the experimenter in the
           medical studio. Then they analyzed and reported in a graph.

        -  Summarizing tables and graphs of the data will be taken during experimentation.
    


Study Type

Interventional


Primary Outcome

Change of the Density of the Hair measured with a camera

Secondary Outcome

 Change of the Amount of Hair Loss

Condition

Alopecia Areata

Intervention

MEXIS/M6S Patent - lotion against alopecia

Study Arms / Comparison Groups

 Volunteers
Description:  20 volunteers both men and women with an age between 18 and 70 years suffering from Alopecia Areata in several types apply on the scalp drops of the MEXIS/M6S PATENT - lotion against Alopecia

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information


Recruitment Status

Other

Estimated Enrollment

20

Start Date

October 2015

Completion Date

October 2017

Primary Completion Date

October 2016

Eligibility Criteria

        Inclusion Criteria:

          -  Good state of general health

          -  Suffering from Alopecia Areata

          -  No pharmacological treatment in progress

          -  Promise not to change the usual daily routine

          -  No atopy in the anamnesis

        Exclusion Criteria:

          -  Illness

          -  Good state of hair

          -  Pharmacological treatment in progress

          -  Denial of the continuance of the usual daily routine

          -  Atopy in the anamnesis
      

Gender

All

Ages

18 Years - N/A

Accepts Healthy Volunteers

Accepts Healthy Volunteers

Contacts

Markos Papakonstantis, Monitor, , [email protected]

Location Countries

Greece

Location Countries

Greece

Administrative Informations


NCT ID

NCT02604888

Organization ID

MEXIS-ALOPECIA AREATA-2015


Responsible Party

Sponsor

Study Sponsor

Mexis George


Study Sponsor

Markos Papakonstantis, Monitor, Study Chair, 401 General Military Hospital of Athens, Dermatology clinic


Verification Date

January 2017